Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.

@article{Hale1988RemissionII,
  title={Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.},
  author={Geoffrey Hale and M J S Dyer and Marcus R. Clark and Janice Mitchell Phillips and R Marcus and Lutz Riechmann and Gerhard Winter and Herman Waldmann},
  journal={Lancet},
  year={1988},
  volume={2 8625},
  pages={1394-9}
}
A genetically reshaped human IgG1 monoclonal antibody (CAMPATH-1H) was used to treat two patients with non-Hodgkin lymphoma. Doses of 1-20 mg daily were given intravenously for up to 43 days. In both patients lymphoma cells were cleared from the blood and bone marrow and splenomegaly resolved. One patient had lymphadenopathy which also resolved. These… CONTINUE READING